ARIAD Announces Continuation of Iclusig Review Related to Article 20 Procedure in Europe
July 14, 2014 at 07:36 AM EDT
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that the Pharmacovigilance Risk Assessment Committee (PRAC) of the European ...